THERAPEUTIC DRUG-MONITORING IN PREGNANCY - RATIONALE AND CURRENT STATUS

被引:16
作者
KNOTT, C [1 ]
REYNOLDS, F [1 ]
机构
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ANAESTHET UNIT,LONDON,ENGLAND
关键词
D O I
10.2165/00003088-199019060-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:425 / 433
页数:9
相关论文
共 74 条
[1]   DIFFERENTIAL TRANS-PLACENTAL BINDING OF VALPROIC ACID - INFLUENCE OF FREE FATTY-ACIDS [J].
ALBANI, F ;
RIVA, R ;
CONTIN, M ;
BARUZZI, A ;
ALTOMARE, M ;
MERLINI, GP ;
PERUCCA, E .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (06) :759-762
[2]   CLINICAL PHARMACOKINETICS OF DIGOXIN 1980 [J].
ARONSON, JK .
CLINICAL PHARMACOKINETICS, 1980, 5 (02) :137-149
[3]   PROTEIN-BINDING OF ANTIEPILEPTIC DRUGS DURING PREGNANCY, LABOR, AND PUERPERIUM [J].
BARDY, AH ;
HIILESMAA, VK ;
TERAMO, K ;
NEUVONEN, PJ .
THERAPEUTIC DRUG MONITORING, 1990, 12 (01) :40-46
[4]   INVITRO PROTEIN-BINDING INTERACTION STUDIES INVOLVING CEFIXIME [J].
BIALER, M ;
WU, WH ;
FAULKNER, RD ;
SILBER, BM ;
YACOBI, A .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1988, 9 (03) :315-320
[5]   EVALUATION OF VALPROIC ACID (VPA) DEVELOPMENTAL TOXICITY AND PHARMACOKINETICS IN SPRAGUE-DAWLEY RATS [J].
BINKERD, PE ;
ROWLAND, JM ;
NAU, H ;
HENDRICKX, AG .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1988, 11 (03) :485-493
[6]  
BOWDLE TA, 1980, J PHARMACOL EXP THER, V213, P97
[7]   VALPROIC ACID DOSAGE AND PLASMA-PROTEIN BINDING AND CLEARANCE [J].
BOWDLE, TA ;
PATEL, IH ;
LEVY, RH ;
WILENSKY, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) :486-492
[8]   PRACTICAL CLINICAL-PHARMACOLOGY - THERAPEUTIC DRUG-MONITORING AND CLINICAL-TRIALS [J].
BRODIE, MJ ;
FEELY, J .
BRITISH MEDICAL JOURNAL, 1988, 296 (6629) :1110-1114
[9]   ALTERATION OF METHYLDOPA ABSORPTION, METABOLISM, AND BLOOD-PRESSURE CONTROL CAUSED BY FERROUS SULFATE AND FERROUS GLUCONATE [J].
CAMPBELL, N ;
PADDOCK, V ;
SUNDARAM, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (04) :381-386
[10]  
CARTER BL, 1986, OBSTET GYNECOL, V68, P555